Search filters

List of works by Jörg Baesecke

AML1/ETO promotes the maintenance of early hematopoietic progenitors in NOD/SCID mice but does not abrogate their lineage specific differentiation

scientific article published in February 2005

Advances in targeting signal transduction pathways

scientific article

Alteration of Akt activity increases chemotherapeutic drug and hormonal resistance in breast cancer yet confers an achilles heel by sensitization to targeted therapy

scientific article published on 21 February 2008

Diverse roles of GSK-3: tumor promoter-tumor suppressor, target in cancer therapy

scientific article published on 08 October 2013

Dominant roles of the Raf/MEK/ERK pathway in cell cycle progression, prevention of apoptosis and sensitivity to chemotherapeutic drugs

scientific article published on 15 April 2010

Enhancing therapeutic efficacy by targeting non-oncogene addicted cells with combinations of signal transduction inhibitors and chemotherapy

scientific article published on 15 May 2010

GSK-3 as potential target for therapeutic intervention in cancer

scientific article

GSK-3beta is a critical mediator of tetrandrine induced cell cycle arrest and cytotoxicity

scientific article

Glycobiology in Malignant Gliomas: Expression and Functions of Galectins and Possible Therapeutic Options ⬇️

scientific article published on September 1, 2012

Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response

scientific article published on September 2012

Occlusion of the femoral arteries in de novo AML

scientific article published in May 2007

PKR activity is required for acute leukemic cell maintenance and growth: a role for PKR-mediated phosphatase activity to regulate GSK-3 phosphorylation

scientific article

Polycythemia vera and D-dimer-negative thromboembolism

scientific article published in October 2005

Primary osteomyelofibrosis and an XX-male genotype

scientific article published on 25 March 2015

Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance

scientific article

Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health

scientific article published on March 2011

Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging

scientific article

The MLL partial tandem duplication in acute myeloid leukaemia

scientific article published on 11 September 2006

The Raf/MEK/ERK pathway can govern drug resistance, apoptosis and sensitivity to targeted therapy

scientific article published on 10 May 2010

Therapy-associated genetic aberrations in patients treated for non-Hodgkin lymphoma

scientific article published in April 2008

Paulina is supported by:

About Paulina

Help